Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;13(2):1517-24.
doi: 10.3892/mmr.2015.4726. Epub 2015 Dec 28.

Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model

Affiliations

Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model

Hui Han et al. Mol Med Rep. 2016 Feb.

Abstract

The transplantation of mesenchymal stem cells (MSCs) is considered to be a promising treatment for ischemic heart disease; however, the therapeutic effects and underlying mechanisms of action require further evaluation. Mitochondrial dysfunction is a key event in simulated ischemia/reperfusion (SI/R) injury. The purpose of the present study was to investigate the mechanism of mitochondrial transfer, which may be involved the antiapoptotic action of co-culture with MSCs. An in vitro model of simulated ischemia/reperfusion (SI/R) was used in the present study. The apoptotic indexes were significantly increased when H9c2 cardiomyocytes were induced in the SI/R group. Following co-culture with bone marrow-derived (BM)-MSCs, H9c2 cells exhibited marked resistance against the SI/R-induced apoptotic process. Besides, mitochondrial transfer via a tunneling nanotube (TNT) like structure was detected by confocal fluorescent microscopy. In addition, following pretreated with latrunculin-A (LatA), an inhibitor of TNT formation, the BM-MSCs were not able to rescue injured H9c2 cells from apoptosis, as previously observed. In conclusion, the anti-apoptotic ability of BM-MSCs may be partially attributed to the recovery of mitochondrial dysfunction in SI/R, and the formation of TNTs appears to be involved in this action of mitochondrial transfer between adjacent cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Identification of isolated BM-MSCs. Flow cytometric analysis of (A) CD90 (B) CD45, (C) CD29 and (D) CD31. The results showed >90% of the BM-MSCs were positive for CD90 or CD29, whereas <3% of the BM-MSCs were positive for CD45 or CD31. BM-MSCs, bone marrow-derived mesenchymal stem cells; CD, cluster of differentiation.
Figure 2
Figure 2
Effects of co-culture with BM-MSCs on apoptosis in the control (Con), SI/R and SI/R co-cultured with BM-MSCs (Co-culture) groups. (A) Changes in apoptotic incidence in the Con, SI/R and Co-culture groups. Data are presented as the mean ± standard deviation. *P<0.05, vs. Con; #P<0.05, vs. SI/R. BM-MSCs, bone marrow-derived mesenchymal stem cells; SI/R, simulated ischemia/reperfusion.
Figure 3
Figure 3
Effects of co-culture with BM-MSCs on apoptosis and mitochondrial membrane potential in the control (Con), SI/R and SI/R co-cultured with BM-MSCs (Co-culture) groups. (A) Representative western blots showing the changes in the expression Bax and Bcl-2 in H9c2 cells from the Con, SI/R and Co-culture groups. (B) Changes in caspase-3 activity in H9c2 cells from the Con, SI/R and Co-culture groups. (C) Changes in mitochondrial membrane potential in H9c2 cells from the Con, SI/R and Co-culture groups. Data are presented as the mean ± standard deviation (*P<0.05, vs. Con; #P<0.05, vs. SI/R). BM-MSCs, bone marrow-derived mesenchymal stem cells; SI/R, simulated ischemia/reperfusion; Bcl-2, B cell lymphoma-2; Bax, Bcl-2-associated X protein; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazole-carbocyanide iodine.
Figure 4
Figure 4
Mitochondria transfer following direct co-culture of ischemia/reperfusion-stimulated H9c2 cells with BM-MSCs. Arrows indicate the TNT-like structures. (A) Blue nucleus stained by DAPI; (B) Green fluorescence from GFP BM-MSCs; (C) Red mitochondria stained by MitoTracker Deep Red; (D) Merge of A–C. The arrows indicate the TNT-like structures. SI/R, simulated ischemia/reperfusion; BM-MSCs, bone marrow-derived mesenchymal stem cells; GFP, green fluorescence protein. GFP, green fluorescence protein; BM-MSCs, bone marrow-derived mesenchymal stem cells.
Figure 5
Figure 5
Evaluation of apoptotic incidence in the SI/R, Co-culture and Pre-LatA groups. Data are presented as the mean ± standard deviation (*P<0.05, vs. SI/R. #P<0.05, vs. Co-culture). BM-MSCs, bone marrow-derived mesenchymal stem cells; SI/R, simulated ischemia/reperfusion; Co-culture, SI/R co-cultured with BM-MSCs; LatA, latrunculin-A; Pre-LatA, pretreated with LatA.
Figure 6
Figure 6
Effects of co-culture with BM-MSCs on apoptosis and mitochondrial membrane potential in the SI/R, Co culture and Pre LatA groups. (A) Representative western blotting of the changes in the expression levels of Bax and Bcl-2 in H9c2 cells. (B) Changes in caspase-3 activity in H9c2 cells from the different groups. (C) Changes in mitochondrial membrane potential in H9c2 cells from the different groups. Data are presented as the mean ± standard deviation (*P<0.05, vs. SI/R; #P<0.05, vs. Co-culture). BM-MSCs, bone marrow-derived mesenchymal stem cells; SI/R, simulated ischemia/reperfusion; Co-culture, SI/R co-cultured with BM-MSCs; LatA, latrunculin-A; Pre-LatA, pretreated with LatA; Bcl-2, B cell lymphoma-2; Bax, Bcl-2-associated X protein; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazole-carbocyanide iodine.

References

    1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et al. Heart disease and stroke statistics-2011 update: A report from the American heart association. Circulation. 2011;123:e18–e209. doi: 10.1161/CIR.0b013e3182009701. - DOI - PMC - PubMed
    1. Forouzanfar MH, Moran AE, Flaxman AD, Roth G, Mensah GA, Ezzati M, Naghavi M, Murray CJ. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart. 2012;7:331–342. doi: 10.1016/j.gheart.2012.10.003. - DOI - PMC - PubMed
    1. Yu D, Li M, Tian Y, Liu J, Shang J. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sci. 2015;122:15–25. doi: 10.1016/j.lfs.2014.11.014. - DOI - PubMed
    1. Chen C, Feng Y, Zou L, Wang L, Chen HH, Cai JY, Xu JM, Sosnovik DE, Chao W. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. J Am Heart Assoc. 2014;3:e000683. doi: 10.1161/JAHA.113.000683. - DOI - PMC - PubMed
    1. Tanaka-Esposito C, Chen Q, Lesnefsky EJ. Blockade of electron transport before ischemia protects mitochondria and decreases myocardial injury during reperfusion in aged rat hearts. Transl Res. 2012;160:207–216. doi: 10.1016/j.trsl.2012.01.024. - DOI - PMC - PubMed

Publication types

MeSH terms